Therapies, Investigational
"Therapies, Investigational" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Treatments which are undergoing clinical trials or for which there is insufficient evidence to determine their effects on health outcomes; coverage for such treatments is often denied by health insurers.
| Descriptor ID |
D035703
|
| MeSH Number(s) |
E02.931
|
| Concept/Terms |
Therapies, Investigational- Therapies, Investigational
- Investigational Therapy
- Therapy, Investigational
- Investigational Treatments
- Investigational Treatment
- Treatment, Investigational
- Treatments, Investigational
- Experimental Therapies
- Experimental Therapy
- Therapies, Experimental
- Therapy, Experimental
- Investigational Therapies
|
Below are MeSH descriptors whose meaning is more general than "Therapies, Investigational".
Below are MeSH descriptors whose meaning is more specific than "Therapies, Investigational".
This graph shows the total number of publications written about "Therapies, Investigational" by people in this website by year, and whether "Therapies, Investigational" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2013 | 0 | 2 | 2 |
| 2014 | 2 | 0 | 2 |
| 2016 | 0 | 1 | 1 |
| 2017 | 8 | 5 | 13 |
| 2018 | 3 | 3 | 6 |
| 2020 | 6 | 2 | 8 |
| 2021 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Therapies, Investigational" by people in Profiles.
-
Homecare Encounters: An Organizational Response to Innovative Care for Patients Undergoing Hematopoietic Stem Cell Transplantation During COVID-19. Clin J Oncol Nurs. 2021 08 01; 25(4):457-464.
-
Information Opacity in Biopharmaceutical Innovation Through the Lens of COVID-19. Am J Law Med. 2021 07; 47(2-3):157-175.
-
Conference on retroviruses and opportunistic infections (virtual): March 6-10, 2021. EBioMedicine. 2021 Jun; 68:103428.
-
Rapid Implementation of Model-Based Dosing Recommendations During the Coronavirus Disease 2019 Pandemic. JAMA Pediatr. 2021 04 01; 175(4):432-433.
-
Developing therapeutic approaches for twenty-first-century emerging infectious viral diseases. Nat Med. 2021 03; 27(3):401-410.
-
Investigational Treatments for COVID-19 may Increase Ventricular Arrhythmia Risk Through Drug Interactions. CPT Pharmacometrics Syst Pharmacol. 2021 02; 10(2):100-107.
-
An update review of emerging small-molecule therapeutic options for COVID-19. Biomed Pharmacother. 2021 May; 137:111313.
-
Ethics of emerging infectious disease outbreak responses: Using Ebola virus disease as a case study of limited resource allocation. PLoS One. 2021; 16(2):e0246320.
-
Early experimental COVID-19 therapies: associations with length of hospital stay, mortality and related costs. Swiss Med Wkly. 2020 12 14; 150:w20446.
-
Drug interactions: a review of the unseen danger of experimental COVID-19 therapies. J Antimicrob Chemother. 2020 12 01; 75(12):3417-3424.